세계의 조직 공학 시장 : 제품, 용도, 최종 사용자별 예측(2025-2030년)

The Tissue Engineering Market was valued at USD 43.13 billion in 2023, expected to reach USD 51.21 billion in 2024, and is projected to grow at a CAGR of 18.82%, to USD 144.28 billion by 2030.

Tissue engineering is a multidisciplinary field that harnesses principles from biology, engineering, and clinical sciences to develop functional substitutes for damaged tissues and organs. It aims to solve significant healthcare challenges by offering alternatives to traditional transplantations, thereby addressing the shortage of donor organs. The scope includes applications in regenerative medicine, disease modeling, drug testing, and in vitro diagnostics. Key end-use segments are in the healthcare industry, particularly in orthopedics, neurology, and cardiovascular treatments. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing geriatric population. Technological innovations-such as advanced 3D bioprinting techniques, development of biomaterials, and stem cell research-serve as significant influencers. Furthermore, increasing governmental support and funding for research contribute positively. The field offers substantial opportunities, particularly in personalized medicine and organ regeneration. To capitalize on these opportunities, businesses can focus on pioneering stem cell applications and developing innovative scaffold technologies. Despite its promising prospects, the market faces several challenges, including high development costs, regulatory hurdles, and ethical concerns surrounding stem cell use. Limitations also arise from technological constraints in replicating complex tissue structures. Companies aiming for growth should focus on areas like biofabrication and the creation of more sophisticated in vitro tissue models. The nature of the tissue engineering market is highly innovative and rapidly evolving, characterized by constant research and development activities aimed at overcoming current limitations. Businesses must stay abreast of technological advances and regulatory changes while forging strategic partnerships and investing in comprehensive R&D to drive innovation. Overall, the field holds vast potential, but it requires careful navigation through existing challenges to achieve sustainable commercial success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Engineering Market

The Tissue Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Potential need for tissue engineering procedures in treating irreversible damage of tissues
  • Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
  • Growing use of biogenic nanoparticles for advanced tissue engineering applications
• Market Restraints
  • Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
• Market Opportunities
  • Technological advancements in the field of 3D tissue engineering
  • Surging government support for tissue engineering research projects
• Market Challenges
  • Stringent government regulations associated with tissue engineering

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Engineering Market

A detailed market share analysis in the Tissue Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Engineering Market

A strategic analysis of the Tissue Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspect Biosystems Ltd., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Cook Group Incorporated, Corning Incorporated, CTIBiotech, Frequency Therapeutics, Gel4Med, General Electric Company, Humacyte, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Miromatrix Medical, Inc., Modern Meadow, Novartis AG, Organogenesis Inc., Organovo Holdings, Inc., Pfizer Inc., Prellis Biologics, ReproCell Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regeneration Systems Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biomaterials, Equipment, and Services. The Biomaterials is further studied across Cell Sources, Growth Factors & Bioactive Molecules, and Scaffold Materials. The Scaffold Materials is further studied across Composite Scaffold Materials, Nano-Scaffold Materials, Natural Biological Scaffold Materials, and Synthetic Biodegradable Polymer Scaffold Materials. The Equipment is further studied across Bioreactors, Cell Culture Chambers, and Image & Flow Cytometers.
• Based on Application, market is studied across Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development, Orthopedic Applications, Regenerative Medicine, and Wound Healing.
• Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Potential need for tissue engineering procedures in treating irreversible damage of tissues
    • 5.1.1.2. Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
    • 5.1.1.3. Growing use of biogenic nanoparticles for advanced tissue engineering applications
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in the field of 3D tissue engineering
    • 5.1.3.2. Surging government support for tissue engineering research projects
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations associated with tissue engineering
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tissue Engineering Market, by Product

• 6.1. Introduction
• 6.2. Biomaterials
  • 6.2.1. Cell Sources
  • 6.2.2. Growth Factors & Bioactive Molecules
  • 6.2.3. Scaffold Materials
    • 6.2.3.1. Composite Scaffold Materials
    • 6.2.3.2. Nano-Scaffold Materials
    • 6.2.3.3. Natural Biological Scaffold Materials
    • 6.2.3.4. Synthetic Biodegradable Polymer Scaffold Materials
• 6.3. Equipment
  • 6.3.1. Bioreactors
  • 6.3.2. Cell Culture Chambers
  • 6.3.3. Image & Flow Cytometers
• 6.4. Services

7. Tissue Engineering Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular Applications
• 7.3. Dental & Craniofacial Applications
• 7.4. Drug Testing & Development
• 7.5. Orthopedic Applications
• 7.6. Regenerative Medicine
• 7.7. Wound Healing

8. Tissue Engineering Market, by End-User

• 8.1. Introduction
• 8.2. Academic & Government Research Institutes
• 8.3. Biotechnology & Pharmaceutical Companies
• 8.4. Contract Research Organizations

9. Americas Tissue Engineering Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tissue Engineering Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineering Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
  • 12.3.2. Essent Biologics Launches Revolutionary Human Native Tissue-Derived Type I Collagen
  • 12.3.3. BioMed X Extends Research Collaboration ith AbbVie On Immunology And Tissue Engineering
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Aspect Biosystems Ltd.
• 3. B. Braun SE
• 4. Baxter International Inc.
• 5. Bayer AG
• 6. Becton, Dickinson and Company
• 7. Cook Group Incorporated
• 8. Corning Incorporated
• 9. CTIBiotech
• 10. Frequency Therapeutics
• 11. Gel4Med
• 12. General Electric Company
• 13. Humacyte, Inc.
• 14. Integra LifeSciences Corporation
• 15. Johnson & Johnson Services, Inc.
• 16. Medtronic PLC
• 17. Merck KGaA
• 18. Miromatrix Medical, Inc.
• 19. Modern Meadow
• 20. Novartis AG
• 21. Organogenesis Inc.
• 22. Organovo Holdings, Inc.
• 23. Pfizer Inc.
• 24. Prellis Biologics
• 25. ReproCell Inc.
• 26. Smith & Nephew PLC
• 27. Stryker Corporation
• 28. Tissue Regeneration Systems Inc.
• 29. Vericel Corporation
• 30. Zimmer Biomet Holdings, Inc.